Evidence mapPaperPMID 36435583Full record

ArticleAtencion primaria2022

[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].

Domingo Orozco-Beltrán, Carlos Brotons Cuixart, Jose R Banegas Banegas, Vicente F Gil Guillén, Ana M Cebrián Cuenca, Enrique Martín Rioboó, Ariana Jordá Baldó, Johanna Vicuña, Jorge Navarro Pérez

Registry-linked trialOpen access · goldAbstract readEnglish Abstract
In one paragraph

Article in Atencion primaria, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06222775 (Multicomponent Intervention on Lifestyle, Anthropometric Measurements, Glycemic Control and Quality of Life in Patients Obese People With Type II Diabetes), which is not on this map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06222775 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Multicomponent Intervention on Lifestyle, Anthropometric Measurements, Glycemic Control and Quality of Life in Patients Obese People With Type II Diabetes

TypeinterventionalSponsorCastilla-La Mancha Health ServiceRan2023 to 2025Enrolled100ConditionsObesity, Diabetes Mellitus, Type 2ArmsGroup session 1, Group session 2, Group session 3, Group session 4, Group session 5
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Prostate Cancer and the Mevalonate Pathway.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Domingo Orozco-BeltránMedicina Familiar y Comunitaria, Unidad de Investigación Centro de Salud Cabo Huertas, Departamento San Juan de Alicante. Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan de Alicante, España. Electronic address: dorozcobeltran@gmail.com.
Carlos Brotons CuixartMedicina Familiar y Comunitaria. Instituto de Investigación Biomédica (IIB) Sant Pau. Equipo de Atención Primaria Sardenya, Barcelona, España.
Jose R Banegas BanegasMedicina Preventiva y Salud Pública, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, España.
Vicente F Gil GuillénMedicina Familiar y Comunitaria, Hospital Universitario de Elda. Departamento de Medicina Clínica. Universidad Miguel Hernández, San Juan de Alicante, España.
Ana M Cebrián CuencaMedicina Familiar y Comunitaria, Centro de Salud Cartagena Casco Antiguo, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, España.
Enrique Martín RioboóMedicina Familiar y Comunitaria, Especialista en Medicina Familiar y Comunitaria, Centro de Salud Poniente, Córdoba, IMIBIC Hospital Reina Sofía Córdoba. Colaborador del grupo PAPPS.
Ariana Jordá BaldóMedicina Familiar y Comunitaria, Centro de Salud San Miguel, Plasencia, Badajoz, España.
Johanna VicuñaMedicina Preventiva y Salud Pública, Hospital de la Sant Creu i Sant Pau, Barcelona, España.
Jorge Navarro PérezMedicina Familiar y Comunitaria, Hospital Clínico Universitario. Departamento de Medicina. Universidad de Valencia. Instituto de Investigación INCLIVA, Valencia, España.
Universitat de Miguel Hernández d'Elx · ESHospital de Sant Pau · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESInstituto Murciano de Investigación Biosanitaria · ESSociedad Andaluza de Medicina Familiar y Comunitaria · ESUniversidad Autónoma de Madrid · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; cardiovascular (CV) risk and recommendations for the calculation of CV risk; main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation, and recommendations for management of chronic conditions. The quality of testing and the strength of the recommendation are included in the main recommendations.

Indexed as

Atrial FibrillationDyslipidemiasHypertensionHealth PromotionHumansRisk FactorsAtención primariaCardiovascular diseasesChronic care modelChronic Care ModelDiabetes mellitusEnfermedades cardiovascularesFamily medicineMedicina de familiaPrimary care

Identifiers

PMID36435583
PMCPMC9705225
OpenAlexW4309731122

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.